S90652 in Paediatric Hypertension
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-04-11
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 50
- Registration Number
- NCT00202553
- Locations
- 🇫🇷
Hôpital Necker Enfants Malades, Paris, France
Efficacy and Safety of Ivabradine on Top of Atenolol in Stable Angina Pectoris
Phase 3
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2018-03-15
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 750
- Registration Number
- NCT00202566
- Locations
- 🇨🇦
Montreal Heart Institute, Montreal, Quebec, Canada
Efficacy and Safety of S18986 in the Treatment of Mild Cognitive Impairment Patients
Phase 2
Terminated
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 38
- Registration Number
- NCT00202540
- Locations
- 🇫🇷
Hôpital la Grave-Casselardit, Toulouse, France
Efficacy and Safety of Ivabradine in Severe Congestive Heart Failure
Phase 2
Completed
- Conditions
- First Posted Date
- 2005-09-20
- Last Posted Date
- 2024-07-25
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 12
- Registration Number
- NCT00202579
- Locations
- 🇮🇹
Policlinico San Matteo, Pavia, Italy
The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2005-09-02
- Last Posted Date
- 2018-04-12
- Lead Sponsor
- Institut de Recherches Internationales Servier
- Target Recruit Count
- 10917
- Registration Number
- NCT00143507
- Locations
- 🇬🇧
Royal Brompton National Heart and Lung Hospital, London, United Kingdom
© Copyright 2024. All Rights Reserved by MedPath